New application of CELLECTRAA electroporation technology dramatically enhances ability of DNA therapy to stimulate blood vessel growth and recovery from debilitation caused by blocked arteries of the legs Results published in peer-reviewed Journal of Vascular Surgery Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovio's Electroporation ... (more)
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Synthetically-Optimized-HIF-1-Alpha-DNA-Delivered-/ArticleNewsFeed/Article/detail/818229?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Synthetically-Optimized-HIF-1-Alpha-DNA-Delivered-/ArticleNewsFeed/Article/detail/818229?ref=25
No comments:
Post a Comment